Compare TELA & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TELA | CLIR |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.5M | 31.6M |
| IPO Year | 2019 | 2011 |
| Metric | TELA | CLIR |
|---|---|---|
| Price | $0.74 | $0.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $3.31 | $2.00 |
| AVG Volume (30 Days) | 56.4K | ★ 135.3K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.80 | 15.38 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,300,000.00 | $530,000.00 |
| Revenue This Year | $18.41 | $13.13 |
| Revenue Next Year | $15.20 | $143.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 18.56 | N/A |
| 52 Week Low | $0.67 | $0.42 |
| 52 Week High | $2.48 | $1.12 |
| Indicator | TELA | CLIR |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 22.54 |
| Support Level | $0.67 | N/A |
| Resistance Level | $1.20 | $0.62 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 34.38 | 4.38 |
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.